0001562180-18-002921.txt : 20180607 0001562180-18-002921.hdr.sgml : 20180607 20180607172146 ACCESSION NUMBER: 0001562180-18-002921 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180605 FILED AS OF DATE: 20180607 DATE AS OF CHANGE: 20180607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HILLEMAN JERYL L CENTRAL INDEX KEY: 0001216628 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36545 FILM NUMBER: 18887420 MAIL ADDRESS: STREET 1: C/O INTERSECT ENT, INC. STREET 2: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intersect ENT, Inc. CENTRAL INDEX KEY: 0001271214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 200280837 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-641-2100 MAIL ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: SINEXUS INC DATE OF NAME CHANGE: 20031124 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-06-05 false 0001271214 Intersect ENT, Inc. XENT 0001216628 HILLEMAN JERYL L C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025 false true false false Chief Financial Officer Common Stock 2018-06-05 4 M false 12833.00 11.12 A 36265.00 D Common Stock 2018-06-05 4 S false 12833.00 41.7007 D 23432.00 D Stock Option (right to buy) 11.12 2018-06-05 4 M false 12833.00 0.00 D 2024-06-10 Common Stock 12833.00 21000.00 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.45 to $42.10, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The shares subject to the option vest commencing June 4, 2014. 25% of the shares subject to the option vested on June 4, 2015 and 1/48th of the shares subject to the option vests monthly thereafter over three (3) years. /s/ Jeryl L. Hilleman 2018-06-07